Did you know?
Mild cognitive impairment (MCI) is related to Alzheimer's disease, the most common type of dementia. MCI causes a slight but noticeable decline in mental abilities, such as memory and thinking.
- It is estimated that 1 in 3 Australians over the age of 70 have MCI
- People with MCI have a higher risk of getting dementia
- There are no effective treatments for MCI.
This short study aims to increase our knowledge of the brain activity of people with MCI. This is important for understanding the disease and how it works as well as for the development of future treatments.
- A short screening session over the phone
- A face-to-face screening session
- Three study visits over a 1 week period:
- A physiological assessment
- An assessment of your mental abilities
- An MRI scan
What are the benefits of participating?
- You will receive feedback about your mental condition at the end of the study, and information on what you can do to reduce your risk of future cognitive decline including further clinical trial opportunities if applicable.
- You will be compensated $120 for your travel expenses.
You will be helping to advance medical research, which could assist in the development of effective treatments in the future for people with MCI or dementia.